Loss of beta cell function as fasting glucose increases in the non-diabetic range (Q44975445)

7 December 2017

Loss of beta cell function as fasting glucose increases in the non-diabetic range (English)

1 reference

7 December 2017

0 references

I F Godsland

1

1 reference

PubMed ID

15249997

7 December 2017

J A R Jeffs

series ordinal

2

1 reference

PubMed ID

15249997

7 December 2017

D G Johnston

series ordinal

3

1 reference

7 December 2017

13 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

47

1 reference

7 December 2017

1157-1166

1 reference

7 December 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-004-1454-z

7 December 2017

0 references

cites work

The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Glucose-stimulated signaling pathways in biphasic insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men--report from 27 years of follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Contribution of insulin secretion and clearance to glucose-induced insulin concentration in african-american and caucasian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Insulin resistance and associated compensatory responses in african-american and Hispanic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Risk factors for NIDDM in white population. Paris prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Impaired fasting glucose: how low should it go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Relationships Between Fasting Plasma Glucose Levels and Insulin Secretion During Intravenous Glucose Tolerance Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Relative conributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Decreased insulin secretion and dyslipidemia coexist in subjects with impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

An apparently anomalous relationship between insulin and C-peptide concentrations in their initial response to intravenous glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1454-Z

Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men.

21 January 2018

1 reference

12 December 2020

The kinetics of insulin in man. II. Role of the liver

1 reference

12 December 2020

Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure

1 reference

12 December 2020

Modeling of plasma disappearance of unlabeled insulin in man

1 reference

12 December 2020

Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion

1 reference

12 December 2020

The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity.

1 reference

12 December 2020

Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity

1 reference

12 December 2020

Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method.

1 reference

12 December 2020

A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties

1 reference

12 December 2020

Quantitative estimation of insulin sensitivity

1 reference

12 December 2020

An analogue computer model for the insulin response to glucose infusion

1 reference

12 December 2020

10.1007/S00125-004-1454-Z

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

15249997